3. #vaccination reduces the viral load by 1.6x to 20x in individuals who are positive for SARS-CoV-2
4. This estimate might improve after more individuals receive the second dose
While the article preprinted ⬆️ has not been peer-reviewed yet, it does show:
1. #PfizerBiontech#vaccine is effective at preventing COVID19
2. Vaccine does NOT ONLY protect the individuals who receive it, but is likely to reduce viral shedding thus transmission in the population
After vaccinating 3.5 million people, #Israel has reported that “Among the first fully vaccinated group, there was a 53% reduction in new cases of #COVID19, a 39% decline in hospitalizations, and a 31% drop in severe illnesses from mid-Jan until Feb 6.”
https://t.co/ubCkdzFK6A
“Evolution of variants occur when there is high replication of virus in the community. Viruses will not evolve & mutate when we don't give them unbridled replication. That's why we need to double down on adherence to public health measures” #DrFauci
A debate will be held among #FDA independent experts on Feb 26 relating to the consideration of an #emergency authorizations of the #Johnson & Johnson’s #COVID#vaccine. Preliminary results from clinical trials show that J&J’s single-dose vaccine candidate is safe and effective.
#Israeli experts highlight that the level of protection after the 1st dose of #COVID-19 #vaccination may not be as high as hoped. A 1st data analysis suggests an effectiveness of 33% from 14 days after vaccination in people over 60. However, there are important things to note: ⬇️
According to a recent study that involved brain organoids, genetically engineered mice, and human autopsies, SARS-CoV-2 may infect nerve cells and impede blood flow in the central nervous system. https://t.co/0xgqq7e8Ut
According to a recent preclinical study that appeared in ACS, a nanoparticle-based COVID-19 vaccine could be cheap, safe, and effective. The findings suggest that a single dose could provide robust immunity. It would also be easier to store and transport than current vaccines.
According to scientists, a new variant of #SARS-CoV-2 they believe to have first appeared in #Brazil is already in the United Kingdom. Although the variant is distinct from those first spotted in the U.K. and South Africa, it shares certain mutations.
#AstraZeneca have announced that they will be able to adapt the #COVID19 vaccine against new variants of SARS-CoV-2. Tweaking, producing, and distributing the new #vaccine to the public may take 6 to 9 months.
Sinovac Biotech company has developed a leading #COVID-19 vaccine #coronaVac, which was initially claimed to have 78% efficiency. However, the Chinese vaccine was found to be only 50.38% effective. What are the reasons behind this difference?Learn more through the link in the bio
While the safest way to avoid contracting COVID-19 is wearing a mask, it may cause our skin a slight inconvenience. But how to avoid maskne?
Find out more on our website https://t.co/wZDLC3Krvj in our lifestyle section. As well as many more interesting topics.
@Maxtulisreaaaal @SJofficial I AM AN ELF FROM LEBANON AND I LOVE SUNGMIN
I AM AN ELF FROM LEBANON AND I LOVE SUNGMIN
I AM AN ELF FROM LEBANON AND I LOVE SUNGMIN
I AM AN ELF FROM LEBANON AND I LOVE SUNGMIN
I AM AN ELF FROM LEBANON AND I LOVE SUNGMIN
#WeLoveYouSungmin#SungminIn#SungminStay@SJofficial
@Maxtulisreaaaal @SJofficial I AM AN ELF FROM M'SIA AND I LOVE SUNGMIN
I AM AN ELF FROM M'SIA AND I LOVE SUNGMIN
I AM AN ELF FROM M'SIA AND I LOVE SUNGMIN
I AM AN ELF FROM M'SIA AND I LOVE SUNGMIN
I AM AN ELF FROM M'SIA AND I LOVE SUNGMIN
#WeLoveYouSungmin#SungminIn#SungminStay@SJofficial